• Category: Research
Could waist size determine DR risk?
Research

Could waist size determine DR risk?

Study demonstrates the potential of using weight-adjusted waist index to predict the risk of diabetic retinopathy.
Analysis: Global DR cases on the rise, sparking urgent need for intervention
Research

Analysis: Global DR cases on the rise, sparking urgent need for intervention

Study highlights concerning global, regional, and national trends in DR-related blindness.
Eye blinks naturally keep tempo with music, study finds
Research

Eye blinks naturally keep tempo with music, study finds

Investigators explore how blinking rates synchronize with varying tempo rates—and the corresponding brain wave connection.
Essilor Stellest 2.0 lenses demonstrate superior efficacy in slowing myopia progression
Research

Essilor Stellest 2.0 lenses demonstrate superior efficacy in slowing myopia progression

Upgraded FDA-authorized spectacle lenses for pediatric myopia control found to slow axial elongation more effectively after 1 year with advanced technology.
Study identifies key vitamin supplementation for NCP
Research

Study identifies key vitamin supplementation for NCP

Vitamins B3, 12, and D may offer new therapeutic approaches to neuropathic corneal pain management.
DR risk may significantly increase with low hemoglobin levels
Research

DR risk may significantly increase with low hemoglobin levels

New research found low levels independently increased the risk among diabetic patients—with a strong association for proliferative DR.
The Dry Eye Society of the Americas launches as new nonprofit
Research

The Dry Eye Society of the Americas launches as new nonprofit

Founded by leading dry eye specialists, DESA intends to establish dry eye as a recognized subspecialty.
New 5-year Syfovre data indicates extended delay of GA progression
Research

New 5-year Syfovre data indicates extended delay of GA progression

GALE extension study findings show delayed GA lesion growth by an estimated 1.5 years in patients receiving continuous treatment.
Nearly 50% of adults with keratoconus still facing high rate of progression
Research

Nearly 50% of adults with keratoconus still facing high rate of progression

Study finds, across all age groups, patients with advanced disease were most at risk of keratoconus progression.
Antidepressant use may lower AMD risk
Research

Antidepressant use may lower AMD risk

Study outlines potential explanations for link between antidepressant use and reduced risk of AMD onset and progression.
RGC thickness may be early retinal indicator with oral HCQ
Research

RGC thickness may be early retinal indicator with oral HCQ

Screening with SD-OCT may aid in identifying patients with retinal toxicity before visual field loss.
Advanced AMD linked to imbalanced gut microbiome
Research

Advanced AMD linked to imbalanced gut microbiome

Though seemingly unrelated, gut flora may play a surprising role in the pathogenesis of age-related macular degeneration (AMD).
Viatris and Locus Biosciences to develop antibacterial therapies for ophthalmic infections
Research

Viatris and Locus Biosciences to develop antibacterial therapies for ophthalmic infections

Collaboration will utilize Locus’ advanced precision drug development platform to address increasing burden of antimicrobial resistance in eye infections.
Myopia may delay DR development and progression
Research

Myopia may delay DR development and progression

Study used Mendelian randomization to identify a causal relationship between myopia and diabetic retinopathy.
Women with osteoporosis more prone to AMD development
Research

Women with osteoporosis more prone to AMD development

Study highlights the key role of declining estrogen levels in the risk of developing AMD and osteoporosis.
Atopic dermatitis linked to increased risk for AMD
Research

Atopic dermatitis linked to increased risk for AMD

Study highlights importance of monitoring adult patients with atopic dermatitis for signs of AMD.
Lower AMD risk tied to long-term metformin use
Research

Lower AMD risk tied to long-term metformin use

Study joins growing body of research on the protective effect of metformin against AMD risk in diabetic patients.
Real-world data support IZERVAY's long-term benefits
Research

Real-world data support IZERVAY's long-term benefits

OLE trial of the GATHER2 study finds continued GA lesion growth for up to 3.5 years—with earlier intervention offering greater protection of the retinal tissue.
Physical activity tied to decreased glaucoma progression
Research

Physical activity tied to decreased glaucoma progression

Study highlights several ways that exercise may reduce the risk of progression in POAG patients.
Study: DR, DME patients most likely to miss follow-up care
Research

Study: DR, DME patients most likely to miss follow-up care

Multiple demographic and socioeconomic factors identified in association with loss to follow-up care in patients with PDR and DME.